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Abstract: The identification of patient subgroups with differential treatment effects is the first step towards
individualised treatments. A current draft guideline by the EMA discusses potentials and problems in
subgroup analyses and formulated challenges to the development of appropriate statistical procedures
for the data-driven identification of patient subgroups. We introduce model-based recursive partitioning as
a procedure for the automated detection of patient subgroups that are identifiable by predictive factors. The
method starts with a model for the overall treatment effect as defined for the primary analysis in the study
protocol and uses measures for detecting parameter instabilities in this treatment effect. The procedure
produces a segmented model with differential treatment parameters corresponding to each patient sub-
group. The subgroups are linked to predictive factors by means of a decision tree. The method is applied to
the search for subgroups of patients suffering from amyotrophic lateral sclerosis that differ with respect to
their Riluzole treatment effect, the only currently approved drug for this disease.
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1 Introduction
With the rise of personalised medicine, the search for individual treatments poses challenges to the
development of appropriate statistical methods. Subgroup analyses following a traditional statistical
assessment of an overall treatment effect of a new therapy aim at identifying three groups of patients: (1)
those who benefit from the new therapy, (2) those who do not benefit, and (3) those whose clinical outcome
under the new therapy is worse than under alternative therapies. Such post-hoc subgroup analyses
potentially lead to better benefit-risk decisions and treatment recommendations but are subject to all
kind of biases and can hardly be performed under full statistical error control. Therefore, the European
Medicines Agency (EMA) recently published a draft of a guideline for the investigation of subgroups in
confirmatory clinical trials [1] that discusses potential areas of application, necessity, pitfalls, and good
practice in subgroup analyses. In the guideline draft, three scenarios in which exploratory investigation of
subgroups is of special interest were identified:
Scenario 1: “The clinical data presented are overall statistically persuasive with therapeutic efficacy
demonstrated globally. It is of interest to verify that the conclusions of therapeutic efficacy (and safety)
apply consistently across subgroups of the clinical trial population.”
Scenario 2: “The clinical data presented are overall statistically persuasive but with therapeutic efficacy or
benefit/risk which is borderline or unconvincing and it is of interest to identify post-hoc a subgroup,
where efficacy and risk-benefit is convincing.”
Scenario 3: “The clinical data presented fail to establish statistically persuasive evidence but there is
interest in identifying a subgroup, where a relevant treatment effect and compelling evidence of a
favourable risk-benefit profile can be assessed.”
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Especially in trials with highly heterogeneous study populations, subgroup analyses can help to reduce the
variability of the estimated overall treatment effect by splitting the study population into more homoge-
neous subgroups.
Information about the individual treatment effect might be available from cross-over trials or from counter-
factual analyses of parallel-group designs [2, 3]. These individual effects can then be linked to potentially
predictive variables. In the absence of such information, most importantly in the case of parallel-group designs
studied here, subgroup analyses can be seen as the search for or specification of treatment × covariate
interactions and we proceed along this path. A covariate measures a patient characteristic that potentially
explains the patient’s individual treatment effect. In the commonly applied models with linear predictors, such
as the linear, generalised linear or linear transformation models, the specification of higher-order interaction
terms and especially the subsequent inference are known to be burdensome. For non-categorical covariates, it is
a priori unclear how one can derive a subgroup from a significant treatment × covariate interaction.
Automated interaction detection [4], today known as recursive partitioning methods or simply “trees”, was
suggested as an interaction search procedure more than 50 years ago, and has had a very active development
community ever since. Although the application of trees for subgroup identification seems to be straightfor-
ward, no generally applicable method is available [5]. The main technical problem is that classical trees were
developed for identifying higher-order covariate interactions but additional work is required to restrict inter-
actions to treatment × covariate interactions. Due to the non-parametric nature of most tree models, blending
trees with the linear models typically used to describe the treatment effect is challenging.
While setting up such automated procedures for subgroup identification, one has to bear in mind that the
impact of a covariate on the endpoint can be prognostic, predictive, or both. Prognostic factors have a direct
impact on the endpoint, independent of the treatment applied. This corresponds to a main effect. A predictive
factor explains a differential treatment effect, i.e. a treatment × covariate interaction term. Both the main and
the treatment interaction terms are important for factors that are prognostic and predictive at the same time [6].
In our analysis, we aimed at detecting subgroups of patients suffering from amyotrophic lateral
sclerosis (ALS) in which the subgroups differ in the effect of treatment with Riluzole, the only approved
drug for ALS treatment today. The two endpoints of interest are a functional endpoint assessing the
patient’s ability to handle daily life and the overall survival time. We estimated the overall treatment effect
of Riluzole using four different base models; the choice of the model depended on the measurement scale of
the endpoint. A normal generalised linear model (GLM) with log-link was used for the sum-score of the
functional endpoint, and item-specific proportional odds models were used for the decomposed score. For
the right-censored survival times, we used a parametric Weibull model and a semiparametric Cox model.
Our aim was to partition these linear models with respect to the treatment effect parameter and to develop a
segmented model that includes treatment × covariate interactions that describe the relevant subgroups.
We applied model-based recursive partitioning [7] to the functional and survival models describing the
effect of Riluzole on ALS patients in order to obtain subgroups with a differential treatment effect. The main
advantage of embedding our subgroup analysis into this general framework of model partitioning is that
one can partition the base model used for analysing the overall treatment effect, regardless of the
measurement scale of the endpoint. The method allows us to focus attention on predictive factors, while
other terms, such as the effects of strata or nuisance parameters, can be held fixed.
Section 2 introduces the general framework for subgroup identification and compares the new proce-
dure to methods published previously in the light of this general theoretical framework. In Section 3, we
present results of our subgroup analysis of Riluzole treatment of ALS patients and discuss the patient
subgroups and corresponding differential treatment effects found.
2 Model-based recursive partitioning for subgroup identification
Subgroup analyses require the definition of a parameter describing the treatment effect. In clinical trials,
this parameter is typically already contained in the model that was defined in the study protocol for the
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analysis of the primary endpoint. The treatment effect was estimated in the primary analysis under the
assumption that the corresponding parameter is universally applicable to all patients. In the presence of
subgroups, this assumption does not hold and these patient subgroups differ in their treatment effect. If
we assume that the different treatment effects can be understood as a function of patient characteristics,
the patient subgroups can be identified by estimating this treatment effect function. Model-based
recursive partitioning can be employed as a procedure for the estimation of such a treatment effect
function and the identification of the corresponding patient subgroups. The name of the procedure comes
from the nature of the algorithm that recursively partitions the initial model used for the analysis of the
primary endpoint.
2.1 Model and algorithm
We started with a modelmððY,XÞ, ϑÞ that describes the conditional distribution of the primary endpoint Y
(or certain characteristics of this distribution) as a function of the treatment arm and potentially further
covariates (both contained in X) through parameters ϑ as defined in the study protocol. The parameter
vector ϑ= ðα, β, γ, σÞ` typically contains one or more intercept parameters α, one or more treatment effect
parameters β, other model parameters γ, e.g. effects of covariates, and potential nuisance parameters σ, e.g.
the error variance in a linear model. The estimator is defined as the minimizer of an objective function Ψ,
which usually is the negative log-likelihood:
ϑ^= argmin
ϑ
XN
i= 1
Ψððy, xÞi, ϑÞ. (1)
Estimating ϑ is equivalent to solving the score equation
XN
i= 1
∂Ψððy,x Þi, ϑÞ
∂ϑ
=
XN
i= 1
ψððy,xÞi, ϑÞ=0, (2)
where ψ is the score function, i.e. the gradient of the objective function Ψ with respect to ϑ. The model
framework is more general than the log-likelihood framework because Ψ is not necessarily a negative log-
likelihood function.
In the presence of patient subgroups that differ in their treatment effect β, an estimate β^ obtained for all
patients i= 1, . . . ,N in the study only reflects the mean treatment effect but ignores that the success or
failure of a specific treatment might depend on additional characteristics of each individual patient. We
describe patient subgroups as a partition fbbg (b = 1, . . . ,B) of all patients i= 1, . . . ,N. The subgroup-
specific model parameters are then ϑ ðbÞ. These parameters can in general be seen as varying coefficients
[8], however they may depend on several patient characteristics and are always step functions with a
different level for each subgroup and not only a smoothly varying coefficient for one single predictive
variable.
Since we are searching for predictive and prognostic factors, we are only interested in subgroups that
differ in the intercept or the treatment effect or both as explained in Section 2.2. With ϑðbÞ= ðαðbÞ, βðbÞ, γ, σÞ`
we assume that the effects of covariates and nuisance parameters are constant for all patients. The partition
fbbg is defined by J partitioning variables Z= ðZ1, . . . , ZJÞ 2z; in other words, fbbg is a hypercube in the
J-dimensional sample space z. These partitioning variables Z are the additional patient characteristics that
potentially influence αðbÞ and βðbÞ. If for example gender were a predictive factor in a given treatment-
endpoint relationship, it would be a patient characteristic that is involved in forming the partitions. If the
partition fbbg is known, the partitioned model parameters ϑðbÞ could be estimated by minimising the
segmented objective function:
ðϑ^ðbÞÞb= 1, ...,B = argminϑ ðbÞ
XN
i= 1
XB
b= 1
zi 2 bbð ÞΨððy,xÞi, ϑðbÞÞ, (3)
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where denotes the indicator function and ðy,xÞi, zi are the realisations of ðY,XÞ and Z for the i-th
patient. This allows us to write the subgroup-specific intercept and treatment parameters as a function of
the partitioning variables
αðzÞ=
XB
b= 1
ðz 2 bbÞ  αðbÞ and βðzÞ=
XB
b= 1
ðz 2 bbÞ  βðbÞ.
Without any a priori knowledge about the partition fbbg, we want to estimate the functions αðzÞ and
βðzÞ by means of model-based recursive partitioning. The main idea underlying this method is the
ability to detect parameter instabilities, i.e. non-constant parameters in a parametric or semiparametric
model, by looking at the score function. Because we are only interested in detecting non-constant
intercepts αðzÞ and treatment effects βðzÞ, we focus on the partial score functions ψαððY,XÞ, ϑÞ=
∂ΨððY,XÞ, ϑÞ=∂α and ψβððY,XÞ, ϑÞ= ∂ΨððY,XÞ, ϑÞ=∂β. If the model parameters are in fact constant
and do not depend on any of the partitioning variables Z, the partial score functions ψαððY,XÞ, ϑÞ
and ψβððY,XÞ, ϑÞ are independent of Z. Consequently, parameter instability corresponds to a correlation
between either of the partial score functions and at least one of the partitioning variables Z1, . . . ,ZJ . In
order to formally detect deviations from independence between the partial score functions and the
partitioning variables, model-based recursive partitioning utilises independence tests. The null
hypotheses
Hα, j0 : ψαððY,XÞ, ϑ^Þ ? Zj, j= 1, . . . , J
and
Hβ, j0 : ψβððY,XÞ, ϑ^Þ ? Zj, j= 1, . . . , J
for a given modelmððY,XÞ, ϑ^Þ state that the partial score functions with respect to α and β, respectively, are
independent of the partitioning variable Zj (j= 1, . . . , J). Hence, these null hypotheses correspond to an
appropriate model fit regarding the intercept and treatment parameter. Because the partial score functions
under the null hypotheses are at least asymptotically normal in many model families, asymptotic M-
fluctuation tests with appropriate correction for multiplicity were introduced for model-based recursive
partitioning by Zeileis and coworkers [9, 7]. Alternatively, permutation tests can be applied in situations
where asymptotic normality of the partial score is not guaranteed [10] or in cases with small numbers of
observations [11–13], which are common in medicine. Also in this case procedures for multiple testing are
used to cope with a possibly large number of partitioning variables J.
If we can reject at least one of the 2 × J null hypotheses for the global model mððY,XÞ, ϑ^Þ at a pre-
specified nominal level, model-based recursive partitioning selects the partitioning variable Zj* asso-
ciated with the highest correlation to any of the partial score functions. This is usually done by means
of the smallest p-value. The dependency structure between the partitioning variable Zj* and either one
of the partial score functions is described by a simple cut-point model. Once we find an optimal cut-
point Zj* < μ using a suitable criterion [13, 7], we split the patients into two subgroups according to
Zj* < μ. For both subgroups, we estimate two separate models with parameters ϑ^ð1Þ and ϑ^ð2Þ, respec-
tively, obtain the corresponding partial score functions, and test the independence hypotheses. If we
find deviations from independence, we in turn estimate a cut-point in the most highly associated
partitioning variable, and split again. The procedure of testing independence of partial score functions
and partitioning variables is repeated recursively until deviations from independence can no longer be
detected.
Since model-based recursive partitioning is a tree method, in the following we use topic-specific
vocabulary, such as nodes. The root node contains all patients and is the basis for the initial model,
inner nodes represent splits and leaf nodes contain the patients of the different subgroups and specify the
partition-specific models. The paths from root to leaf nodes define the subgroups.
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2.2 Content interpretation
A clearer picture of the interpretation of subgroup-dependent model parameters and distribution of the
partial scores under unstable parameters is best given by means of a partitioned linear model discussed in
the following.
Here xA is a contrast that indicates whether a subject was treated with treatment A (active) but not C
(control) in a two-armed trial and xstratum is a stratum with x= ðxA, xstratumÞ. The conditional distribution of
the primary endpoints Y given treatment and stratum is normal
Y jX=x ~nðα+ βxA + γxstratum, σ2Þ. (4)
The segmented model we want to fit using model-based recursive partitioning reads
Y jX= x,Z= z ~nðαðzÞ + βðzÞxA + γxstratum, σ2Þ, (5)
where γ is the effect of the stratum and the variance σ2 is a nuisance parameter. The objective function for a
patient with observations ðy, xÞ is the negative log-likelihood, when maximum likelihood estimation is used,
or the error sum of squares, when ordinary least squares is used. Yet, both methods lead to the same scores
ψððy,xÞ, ϑ^Þ=
∂Ψððy,xÞ,ϑ
∂α

ϑ= ϑ^
∂Ψððy,xÞ,ϑÞ
∂β

ϑ= ϑ^
0
B@
1
CA
`
=
1
σ2
y − ðα^+ β^xA + γ^xstratumÞ
ðy − ðα^+ β^xA + γ^xstratumÞÞ  xA
 !`
(6)
and thus to the same solution. Note that the partial score function with respect to the intercept is
proportional to the least-square residuals and all further scores are proportional to the product of the
residuals and the respective variable.
A partitioning variable can be predictive, prognostic, or both, and we have to consider the parameters
in the model to understand the nature of a partitioning variable. Figure 1 shows examples for mean primary
endpoints and the corresponding intercept α and treatment effect β. If αðzÞ varies over z, but βðzÞ is
constant, then the components of z are prognostic because the mean primary endpoint varies but not the
treatment effect (see first column of Figure 1). If βðzÞ varies over z and αðzÞ is constant, then the variables in
z are predictive since it means that the mean primary endpoint in one treatment arm stays the same but the
treatment effect changes over z (second column). If both parameters vary, then z is predictive (third
column) or predictive and prognostic at the same time (last column). In the latter situation, the mean
primary endpoint of the second subgroup changes over z and the intercept also changes.
It is also interesting to take a closer look at the partial scores. Figure 2a shows the partial scores with
respect to intercept and treatment parameter that result from a linear model Y jX=x ~nðα+ βxA, σ2Þ
plotted against a partitioning variable z1, which is predictive and prognostic. The data-generating process
of this model was suggested by Loh et al. [14] and is defined as
Figure 1: Possible mean primary endpoint within subgroups resulting from a predictive, prognostic, or predictive and prognostic
variable.
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Y jX=x, Z= z ~nð1.9 + 0.2  xA + 1.8  ðz1 < 0Þ+ 3.6  ðz1 > 0Þ  xA, 0.7Þ, (7)
with XA from bð1, 0.5Þ and Z1 fromnð0; 1Þ. For the example, we used this process to draw a sample of 200
observations.
The partial scores with respect to the intercept ψα fluctuate randomly around zero over the whole range
of z1. The partial scores with respect to the treatment parameter ψβ change. Hence, in this situation, model-
based recursive partitioning would detect a deviation from independence between ψβ and z1 and implement
a split at approximately z1 < 0. There is no chance of finding this cut-point by looking at the least-square
residuals only, since a deviation of independence between ψα and z1 is hardly visible in the scatterplot in
Figure 2: Partial scores of different kinds of variables. The symbols represent the treatment arms C and A as indicated. (a)
Partial scores of a predictive and prognostic variable (eq. (7)). (b) Partial scores of a predictive and prognostic variable (eq. (8)).
(c) Partial scores of a prognostic variable (eq. (9)).
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the left panel of Figure 2a. Figure 2b shows the partial scores obtained with a slightly modified data-
generating process, where instead of ðz1 > 0Þ  xA, one has ðz1 < 0Þ  xA:
Y jX= x,Z= z ~nð1.9 + 0.2  xA + 1.8  ðz1 < 0Þ + 3.6  ðz1 < 0Þ  xA, 0.7Þ. (8)
Here the procedure would split the partial score with respect to the intercept, although z1 is still prognostic
and predictive at the same time.
If we focus on the prognostic variable z1 in the model
Y jX= x,Z= z ~nð2  xA + ðz1 > 0Þ, 0.7Þ, (9)
we see non-random patterns in both scores (see Figure 2c). Since the partial scores with respect to the
treatment parameter are set to zero for treatment arm A, we would split on basis of the scores with respect
to the intercept, just as a consequence of a higher power.
These three examples show that splitting in the partial score with respect to the intercept does not give
any information about whether the partitioning variable is predictive or prognostic. It also does not make
sense to choose to split only in the score with respect to the treatment parameter because one might miss
important cut-points. In order to be able to say whether a partitioning variable is predictive or prognostic, it
is not enough to know which partial scores are responsible for the split. It is necessary to consider the
model parameters in the segmented model. If the treatment parameter β varies in the subgroups, then the
chosen partitioning variables are predictive or both predictive and prognostic. If β is constant, the variables
are only prognostic.
2.3 Relation to established procedures
Traditional approaches for subgroup identification are also based on a model for the primary endpoint, but
the segmentation is implemented by means of varying coefficients. More precisely, the model includes
interactions between treatment and the patient characteristics z in addition to the main effects
EðY jX=x, Z= zÞ = α+ βxA + γTprognosticz+ γTpredictivezxA
= ðα0 + γT0, zzÞð1− xAÞ+ ðα1 + γT1, zzÞxA,
(10)
with α= α0, β= α1 − α0, γTprognostic = γ
T
0, z and γ
T
predictive = γ
T
1, z − γ
T
0, z . The model is known as the “classical approach”
for subgroup analyses [15, 16]. Significant interaction terms γpredictive are in this case subject to the choice of
relevant partitioning variables. However, patient subgroups can only be identified directly in this model for
categorical variables zj since the model has no notion of optimal cut-off points. As the number of potential
partitioning variables J might be large, the simultaneous estimation of all parameters in the model might be
computationally burdensome and associated with a large variance. Regularisation procedures may be applied
for selecting relevant interaction parameters that deviate considerably from zero.
RECPAM [17, 18] goes a step further and fits such models by trees. In every node, a likelihood-ratio test
is computed that compares the segmented model
EðY jX= x,Z= zÞ= α+ β1xA ðzj 2 bkÞ+ β2xA½1− ðzj 2 bkÞ (11)
to the constant model
ðEY jX= xÞ= α+ βxA (12)
for every possible segment bk (k = 1, . . . ,K) induced by all possible cut-off points in zj, i.e. an exhaustive
search is performed. The procedure is applied to all partitioning variables zj (j= 1, . . . , J). The algorithm
then chooses the variable and segmentation that comes along with the highest test statistic. The method is
so far limited to linear models and Cox proportional hazards models, and parameter instabilities can only
be detected in β but not in α.
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A method that is similar in spirit to model-based recursive partitioning, but is limited to normal linear
models, is the Gs method [14] based on the GUIDE algorithm [19, 20]. Instead of using partial scores with
respect to intercept and treatment effect, Gs uses only the least-square residuals (that is, only the partial
score with respect to the intercept). In contrast to model-based recursive partitioning, Gs looks at the
dichotomised (at zero) residuals separately in the two treatment arms. The independency between positive/
negative residual signs and each partitioning variable is tested using a chi-squared test separately for each
treatment. If the partitioning variable is at least ordinal, it is dichotomised by splitting at the mean. The
optimal split variable chosen is the one that induces the highest sum of chi-squared statistics. Looking at
the left panels of Figures 2a and 2b, one can imagine that in these situations the procedure may successfully
find the subgroups. However, in a less clear situation and where the optimal cut-point is not near the mean
of z1, the method will have lower power or will not be able to find a split at all.
Another recently proposed tree algorithm is qualitative interaction trees (QUINT [21]). QUINT searches
for instabilities in the treatment parameter β only, but the resulting partitions have to have different signs in
the parameter. In other words, QUINT aims at finding subgroups in which the treatment effect is the reverse
of that of the other subgroups. The current implementation of QUINT [22] is limited to continuous primary
endpoints. It would be possible to enforce splits that are qualitatively different in model-based recursive
partitioning. This could be achieved by incorporating a criterion that implements a split only if the
treatment effects in the two new subgroups have different signs.
SIDES (subgroup identification based on differential effect search) [23] and SIDEScreen [24] aim at
identifying subgroups of patients with high benefit from a novum compared to the standard treatment.
Although the subgroups are linked to hypercubes in the sample space of Z, they are overlapping and can
therefore not be represented as a tree structure. The methods are based on a cross-validated implementa-
tion of subgroups that were obtained on independent learning samples.
More general approaches blending recursive partitioning with traditional models (known as hybrid,
model, or functional trees in machine learning Gama [25]), include M5 [26], GUIDE [19], CRUISE [27], LOTUS
[28] and maximum likelihood trees [29]. (Bayesian approaches can be found in Chipman, George, and
McCulloch [30]) and (Bernardo, Bayarri, Berger, Dawid, Heckerman, Smith, and West [31]). Except GUIDE,
none of these methods has been studied in the specific context of subgroup analyses so far.
3 Partitioning effects of Riluzole on ALS patients
ALS is a neurodegenerative disease that causes weakness, muscle waste and paralysis. Currently the only
drug on the market for treating ALS is Riluzole (Rilutek). It slows down disease progression but only
modestly prolongs life expectancy by about two months [32]. A more thorough investigation of the
treatment effect of Riluzole in ALS patients is of great importance since a cure is not yet available and
patients usually die within 1.5–4 years after disease onset [33]. We use model-based recursive partitioning
to address the question whether Riluzole has an especially low or high treatment effect on both functional
and survival endpoints of any subgroups of patients.
Our analysis is based on patient information obtained from the PRO-ACT (Pooled Resource Open-
Access ALS Clinical Trials) database [34], which contains data of ALS patients that were involved in one
of several publicly- and privately-conducted clinical trials. The database provides information on patient
survival, functional endpoint (the ALS functional rating scale), Riluzole use, demographics, family
history, patient history, forced and slow vital capacity, laboratory data and vital signs. The data were
fully de-identified and therefore the centres of data ascertainment are not given in the data set. The
participants gave their informed consent, and study protocols were approved in the respective medical
centres. The database was initiated by the non-profit organisation Prize4Life that aims at accelerating
cure and drug development for ALS, for example through the DREAM-Phil Bowen ALS Prediction
Prize4Life challenge [35].
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The ALS Functional Rating Scale (ALSFRS [36]), is a widely used instrument for evaluating the
functional status of patients with ALS even though the uni-dimensionality of the score seems questionable
[37]. It is a sum-score of the following ten items: speech, salivation, swallowing, handwriting, cutting food
and handling utensils, dressing and hygiene, turning in bed and adjusting bed clothes, walking, climbing
stairs, and breathing. Each of these items can have values from zero to four, where four is normal and zero
indicates the inability of performing the respective action. Hence, if the ALSFRS has a value 40, the patient
has normal abilities for all items. The lower the score, the worse is the patient’s status. The items were
measured at several time points during the study period. We focused on the ALSFRS reading approximately
six months after treatment start as the functional endpoint. Approximately means that we used the
measurement closest to six months after treatment start, with a maximal absolute deviation of 20 days.
In addition, we also decomposed the score and modelled the items defining the score separately.
The survival time of patients was measured in days starting with the patient’s enrolment in one of the
trials. For patients without survival information, we used the latest follow-up time given for the patient in
the data as censoring time.
Model-based recursive partitioning was applied to models for the functional and survival endpoints. We
allowed parameter instabilities in both the intercept and the Riluzole treatment effect. Bonferroni-adjusted
permutation tests using test statistics of a quadratic form [13] were applied for assessing independence of
the partial score functions and the partitioning variables and also for cut-point selection. The use of
permutation tests for cut-point selection improves speed compared to the original suggestion of fitting
and comparing models for all reasonable partitions [7]. We restricted the depth of the trees to two levels.
Parameter estimates including confidence intervals are given for the final subgroups. Note that we are
computing the confidence intervals after applying model selection through splitting into subgroups and
thus the intervals should be interpreted with caution. For both endpoints, we used partitioning variables
available at patient enrolment from the following groups of variables: demographics, family history, patient
history, forced and slow vital capacity, laboratory data, and vital signs. We excluded patient records with
missing values at the endpoints; the sample size was N = 2534 for the functional endpoint and N = 3306 with
916 events for the survival endpoint.
3.1 ALSFRS
The ALSFRS six months after treatment start (ALSFRS6) defined the functional endpoint. The sum-score is
positive, and the model needs to adjust for the baseline ALSFRS obtained at treatment start (ALSFRS0). We
used a normal GLM with log-link and offset logðALSFRS0Þ such that the model
E
ALSFRS6
ALSFRS0
jX = x
 
=
EðALSFRS6jX = xÞ
ALSFRS0
= expfα+ βxRg (13)
describes the expected relative change in the ALSFRS over the first six months under treatment. The
treatment (Riluzole/no Riluzole) is indicated by xR. The model was fitted by maximum likelihood.
The time between disease onset and start of treatment, the forced vital capacity (FVC), and the
phosphorus balance are the three partitioning variables selected for the tree given in Figure 3. The FVC
value gives the volume of air in liters that can forcibly be blown out after full inspiration to the lung. A
normal phosphorus balance is between 1 and 1.5 mmol/L. The tree indicates a negative treatment effect of
Riluzole for patients with fewer days between disease onset and start of treatment that have a higher FVC
value (node 4). Therefore, the FVC value is predictive in the group of patients with less than 468 days
between disease onset and treatment start. Patients with more days between disease onset and treatment
start do not seem to have a treatment effect. The fact that the time since onset plays an important role is not
surprising since it is a surrogate for the speed of disease progression [38]. Patients with a slow progression
were seldom included early in one of the studies. Hence a long time between onset and start of treatment
usually stands for a slow progression.
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3.2 ALSFRS items
The model for the ALSFRS sum-score assumes that the effect of Riluzole is the same for the ten items that
define the score. In a more fine-grained analysis, we decomposed the score into its ten items (each ranging
between zero and four) and modelled each item by means of a proportional odds model. For one of the ten
items assessed at six months, e.g. Y6, the model reads
PðY6 ≤ rjX=xÞ = 11 + expð− αr + βxRÞ , (14)
where r =0, . . . , 4 is one of the five possible values of Y . The intercept parameters are now α= ðα0, . . . , α3Þ
and the partial score function ψα is now four dimensional.
As in the previous example, we needed to adjust for the baseline value Y0, i.e. the value of the ALSFRS
item read at the beginning of treatment. This adjustment was implemented by computing separate models;
one each for the observations with a start value k, which allows a baseline-specific intercept and treatment
effect :
PðY6 ≤ rjY0 = k,X = xÞ= 11 + expð− αrk + βkxRÞ
for k =0, . . . , 4. (15)
Therefore, we had a total of five different treatment parameters and 20 different intercepts for each of the
ten different items. Model-based recursive partitioning was used to assess the parameter instability of all
250 parameters simultaneously. Note that some of these parameters could not be estimated owing to too
small of sample sizes; these were simply discarded.
The implementation of the non-standard model in the theoretical and computational framework of
model-based recursive partitioning was straightforward. For every node, we computed the five separate
models for the respective baseline values for each of the ten items and extracted the partial scores.
A stratified permutation test using the baseline values as independent blocks was used to assess parameter
instability. The same procedure was applied for cut-off selection.
The resulting tree (on top of Table 1) contains splits in time between disease onset and treatment start
and in the FVC value. The tree is in good agreement with the tree based on the ALSFRS (Figure 3). The third
split variable is the lymphocyte percentage. Normal lymphocyte concentrations range from 16 to 33%.
Table 1 shows the coefficient values of the models in the terminal nodes for every item and every starting
value of the given item. Empty fields indicate that it was not possible to compute the model. Obviously,
there were not enough observations in models with zero as starting value for any items in any nodes. The
colours in the table indicate whether the effect of Riluzole was positive (blue), negative (pink) or zero (grey).
The colours were assigned on the basis of confidence intervals of the coefficient in the given model.
Riluzole had a positive effect on patients in the partition of terminal node 3 who had a starting value of
4 in item 1 (speech), 3 (swallowing) or 9 (climbing stairs) and on patients in the partition of terminal node 7
that had a starting value of 3 in item 5 (cutting food and handling utensils). Patients in node 4 who had a
starting value of 3 in item 6 (dressing and hygiene) had a negative effect of Riluzole. Riluzole had no effect
on patients in the partition of node 6 which are the patients with more than 584 days between disease onset
and treatment start who have a lymphocyte concentration under 21.5%.
3.3 Survival time
We used both a Weibull model and a Cox model to identify subgroups with differing effects of Riluzole on
the survival endpoint. The application of the model-based recursive partitioning framework in the Weibull
model is straightforward and was introduced by Zeileis et al. [7]. Since the Cox model is a semiparametric
model, where the intercept is a function of time, treated as a nuisance parameter omitted in the partial
likelihood, there is no direct way of obtaining ψα. Because, conceptually, deviance residuals are always
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Table 1: Coefficient and confidence interval of Riluzole use in the terminal nodes for every item and every starting value in the
model-based recursive partitioning with a proportional odds model (ALSFRS items as outcome). Blue indicates a positive effect
of Riluzole, pink a negative effect and grey no effect.
Item No. Start Node  Node  Node  Node 
Speech  

 –. (–., .)
 . (–., .) . (–., .) −. (–., .) −. (–., .)
 . (., .) . (–., .)
Salivation  

 . (–., .) . (–., .) . (–., .) −. (–., .)
 . (–., .) −. (–., .) −. (–., .) −. (–., .)
 . (–., .) −. (–., .)
Swallowing  

 . (–., .) −. (–., .) . (–., .) −. (–., .)
 . (–., .) −. (–., .) −. (–., .) . (–., .)
 . (., .) . (–., .) . (–., .)
Handwriting   −. (–., .)
 −. (–., .) −. (–., .) −. (–., .)
 −. (–., .) . (–., .)
 −. (–., .) . (–., .) −. (–., .) −. (–., .)
 −. (–., .) . (–., .) −. (–., .)
Cutting  
 −. (–., .) −. (–., .)
 . (–., .) . (–., .)
 −. (–., .) −. (–., .) . (–., .) . (., .)
 . (–., .) −. (–., .) −. (–., .) −. (–., .)
Hygiene  

 −. (–., .) −. (–., .)
 −. (–., .) −. (–., –.) . (–., .) . (–., .)
 . (–., .) . (–., .) . (–., .) . (–., .)
Bed  

 −. (–., .) . (–., .)
 . (–., .) −. (–., .) −. (–., .) −. (–., .)
 −. (–., .) −. (–., .) −. (–., .) −. (–., .)
(continued )
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defined as the derivative of the log-likelihood with respect to the intercept, we applied martingale residuals
as ψα. Also worth noting is that both models assume proportional hazards. For the segmented model,
proportional hazards are only assumed within each partition. This has to be kept in mind when interpreting
the treatment effect in different nodes: Parameters with different signs are clearly linked to opposing
treatment effects, but when the parameters only differ in size, it is hard to say whether it is because the
groups differ in treatment effect or because they differ in the hazard function.
3.3.1 Weibull model
The Weibull model is a transformation model of the form
PðY ≤ yjX = xÞ= F logðyÞ− α1 − βxR
α2
 
, (16)
where F is the cumulative distribution function of the Gompertz distribution. Weibull models are fitted via
maximum-likelihood estimation, and therefore the objective function in this case is the negative log-
likelihood and the score function has one column per parameter, i.e. intercept α1, slope parameter β and
scale parameter α2. In the Weibull model, we take the usual intercept as well as the scale parameter as
“intercept”-parameter α= ðα1, α2ÞT because they define the shape of the baseline hazard and hence in some
respect take the role of an intercept. Splitting in the intercept or scale parameter score suggests non-
proportional hazards.
Figure 4 shows that the patient’s age and again the time between onset and treatment start play a role
in the partitioning. Older patients ( > 55.7 years) for whom the time between onset and treatment was longer
than 757 days and very young patients did not seem to benefit at all from the treatment. In the remaining
two groups, life expectancy seemed to be prolonged for patients treated with Riluzole.
3.3.2 Cox model
The use of the Cox model in model-based recursive partitioning is a rather special case, since the baseline
hazard in the Cox model is treated as an infinite-dimensional nuisance parameter and estimation is performed
by minimisation of the negative partial log-likelihood. The Cox proportional hazards model is given by
Table 1: (continued )
Item No. Start Node  Node  Node  Node 
Walking  

 . (–., .) −. (–., .)
 . (–., .) . (–., .)
 . (–., .) . (–., .)
Stairs  
 −. (–., .) −. (–., .) −. (–., .)
 −. (–., .) . (–., .)
 . (–., .) −. (–., .) −. (–., .)
 . (., .) . (–., .) . (–., .) . (–., .)
Respiratory  



 . (–., .) −. (–., .)
H. Seibold et al.: Partitioning for Subgroup Analyses 57
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 18.07.16 15:19
Fi
gu
re
4:
Re
su
lt
s
of
ap
pl
ic
at
io
n
of
m
od
el
-b
as
ed
re
cu
rs
iv
e
pa
rt
it
io
ni
ng
w
it
h
a
W
ei
bu
ll
m
od
el
an
d
da
ta
fr
om
th
e
PR
O
-A
C
T
da
ta
ba
se
w
it
h
su
rv
iv
al
ti
m
e
as
pr
im
ar
y
en
dp
oi
nt
va
ri
ab
le
.
In
ne
r
no
de
s
gi
ve
th
e
sp
lit
va
ri
ab
le
se
le
ct
ed
an
d
th
e
as
so
ci
at
ed
pe
rm
ut
at
io
n
te
st
ba
se
d
p-
va
lu
e
fo
r
th
e
sp
lit
.T
er
m
in
al
no
de
s
gi
ve
th
e
m
od
el
co
ef
fi
ci
en
ts
,i
nc
lu
di
ng
st
an
da
rd
co
nf
id
en
ce
in
te
rv
al
s
an
d
th
e
su
rv
iv
al
cu
rv
es
in
th
e
tw
o
gr
ou
ps
of
tr
ea
tm
en
t.
Ru
gs
in
di
ca
te
ev
en
t
ti
m
es
.
58 H. Seibold et al.: Partitioning for Subgroup Analyses
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 18.07.16 15:19
λðyjxÞ= λ0ðyÞ expðβxRÞ, (17)
where λ is the hazard function and λ0 the baseline hazard function. The partial score function ψα (or better,
ψλ0 ) cannot be easily derived. As surrogate score function, we propose using the martingale residuals as a
score for the baseline hazard, which takes the role of an intercept in the Cox model, and the score residuals
for the treatment parameters β. The score residuals are an intuitive choice because they are the first
derivative of the partial log-likelihood with respect to the parameters. We used martingale residuals to
check whether there is a general difference in the endpoint for different patients, which in parametric
models is usually shown by the score with respect to the intercept. Instability in the martingale residuals
indicates a violation of the proportional hazards assumption. Since the martingale residuals are not
normally distributed, the application of permutation tests is more appropriate than the use of M-fluctuation
tests.
Age and the time between disease onset and start of Riluzole treatment form the segments in this
example. The tree in this example has almost the same splits as the tree in the previous example. Also
estimates support the results of the Weibull example. Again, we did not see much difference between
treated and untreated very young patients. For all other groups, Riluzole treatment led to a slight tendency
for a lower risk of death (Figure 5).
4 Discussion
Model-based recursive partitioning allows the direct segmentation of the model describing the overall
treatment effect as specified in the study protocol. This is the most important benefit of embedding
subgroup analysis into this framework because it would be hard to explain why the overall treatment
effect and the partitioned treatment effect have to be estimated by two different procedures. This renders
the application of suboptimal models unnecessary, such as when a change score is analysed using linear
models [21].
Although we are conceptually only interested in finding predictive factors, we think it is necessary to
allow splits in the partial scores with respect to both intercept and treatment parameter. This procedure will
also detect prognostic factors, but there is a higher chance of including all relevant predictive factors since
one might miss prognostic factors when only the treatment scores are split. In our analysis, we decided on
the nature of the partitioning variables (prognostic or predictive) only when we interpreted the results of the
analysis.
In a model with more covariates than the treatment (e.g. strata), we would still split the partial scores
with respect to intercept and treatment parameter for subgroup analyses. A theoretical assumption is then
that the parameters that are not split stay constant. In practice, this assumption usually does not hold. It is
generally also possible to split more than just the scores with respect to intercept and treatment parameter.
Then the split variables are not restricted to being predictive or prognostic but may have an association
with the effect of the other covariates.
In model-based recursive partitioning, the variable selection in each node is error controlled, i.e. the
probability of selecting a partitioning variable for splitting, when actually all partitioning variables are
independent of the scores, is at most as large as the nominal level. The only drawback of using multiple
testing procedures is in cases where there are many possible partitioning variables that do not contain
information, because with increasing number of noise variables the chance of detecting an actually existing
subgroup goes down. The application of permutation tests has the advantage of taking the correlation
structure among the partitioning variables into account. Furthermore, for small studies or small subgroups,
the exact conditional p-value can be easily approximated up to any desired accuracy; therefore, the method
does not rely on asymptotic arguments. The trees obtained by model-based recursive partitioning allow
straightforward visualisation, potentially enriched with plots illustrating the distribution of the endpoints
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for the different treatment groups in each subgroup. Therefore, the results of such a subgroup analysis are
easily communicated to physicians. Looking at a tree is much easier than trying to understand the meaning
of higher-order interactions in a linear predictor. A general drawback of tree methods is the instability of the
tree structure with respect to small perturbations in the data, whereas the resulting partitions we are
primarily interested in are often relatively stable [13]. Instability in the tree structure can be assessed by
means of the variable selection and split statistics, where it is easy to identify all equally likely splits.
Bootstrap aggregation and forest procedures are well-known for their ability to stabilise single trees [39] at
the cost of interpretability and point into a promising future research direction also for model-based
recursive partitioning.
The statistical properties of the confidence intervals derived from the segmented model await further
attention. Leeb and Pötscher ([40]) discuss the validity of inference after variable selection and claim that it
is difficult if at all possible. Bai and Perron [41], who discuss the construction of confidence intervals after
splitting up the data based on a break point in a single partitioning variable, argue that it is possible. In our
approach we first search for the most appropriate partitioning variable (variable selection) and then search
for the optimal split point (break point selection). To our knowledge there is no literature on inference after
variable and break point selection and thus it is unclear if or how valid confidence intervals can be
computed. In any case the results of such a subgroup analysis have to be confirmed in follow-up trials,
which lowers the necessity of confidence intervals. To be conservative one can see the confidence intervals
for parameters in the subgroup-specific models as shown in our examples as a range of possible values and
hence as a measure of variability rather than significance [42].
It would be interesting to extend the framework of the PRO-ACT database of ALS studies to models for
non-independent data, such as mixed models for longitudinal observations. This would allow ALS disease
progression to be modelled over time, and also a potentially time-varying treatment effect to be assessed. In
our way of modelling the functional endpoint, we include no information about patients that died within
the first six months after treatment start. Joint modelling of the longitudinal functional endpoint and the
survival endpoint is a means of combining all possible information [43].
Despite the deficits of model-based recursive partitioning for subgroup analysis discussed in this
section, we think that the procedure as introduced and illustrated in this paper rather closely resembles
the requirements for statistical procedures in this field as outlined in the EMA guideline [1]. In particular, it
is the most generally applicable procedure with statistical error control and unbiased variable selection [13,
7]. With the available open-source implementation (see following section for details), the method can be
applied straightforwardly elsewhere.
Computational details
An open-source implementation of all methods discussed in this paper and beyond is available in the
partykit package hothorn_partykit:_2014. PRO-ACT data are available at https://nctu.partners.
org/ProACT/ [44]. The source code for reading and cleaning the database is provided in the TH.data
package [45]. The source code for the analyses is provided in the supplementary material. All computations
were conducted using partykit (version 0.8-2) in the R system for statistical computing [46], version 3.1.2).
Listing 1: Code snippet for Weibull model in model-based recursive partitioning using the function
ctree( ) from the partykit package.
## Function to compute Weibull model and return score matrix
mywb <- function(data, weights, parm) {
mod <- survreg(Surv(survival.time, cens) Riluzole,
data = data, subset = weights > 0,
dist = "weibull")
H. Seibold et al.: Partitioning for Subgroup Analyses 61
Bereitgestellt von | UZH Hauptbibliothek / Zentralbibliothek Zürich
Angemeldet
Heruntergeladen am | 18.07.16 15:19
ef <- as.matrix(estfun(mod)[,parm])
ret <- matrix(0, nrow = nrow(data), ncol = ncol(ef))
ret[weights > 0,] <- ef
ret
}
## Compute tree
tree <- ctree(fm, data = data, ytrafo = my.wb,
control = ctree_control(maxdepth = 2,
testtype = "Bonferroni"))
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